Insider Trading activities at Blueprint Medicines Corp (BPMC) , Part 2

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Blueprint Medicines Corp (BPMC) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Blueprint Medicines Corp. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1597264.

Total stock buying since 2015: $2,599,104.
Total stock sales since 2015: $231,789,870.
Total stock option exercises since 2015: $26,716,096.


 1   2   3 
27 insiders reported insider trading activities at Blueprint Medicines Corp (BPMC):
Insider trading activities of Fmr Llc
Insider trading activities of Goldberg Mark Alan
Insider trading activities of Albers Jeffrey W.
Insider trading activities of Hewes L. Becker
Insider trading activities of Mccain Tracey L
Insider trading activities of Namouni Fouad
Insider trading activities of Seely Lynn
Insider trading activities of Haviland Kate
Insider trading activities of Dorsch Marion
Insider trading activities of Durso-bumpus Debra
Insider trading activities of Tepper Robert I
Insider trading activities of Demetri George
Insider trading activities of Carter Percy H.
Insider trading activities of Levin Mark J
Insider trading activities of Borisy Alexis
Insider trading activities of Lydon Nicholas
Insider trading activities of Lengauer Christoph
Insider trading activities of Boral Anthony L.
Insider trading activities of Rowland Charles A Jr
Insider trading activities of Landsittel Michael
Insider trading activities of Coats Lonnel
Insider trading activities of Lee Philina
Insider trading activities of Lynch Daniel
Insider trading activities of Hurley Ariel
Insider trading activities of Rossi Christina
Insider trading activities of Murray Christopher K.
Insider trading activities of Starr Kevin P

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Blueprint Medicines Corp (BPMC).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 119,647 $11,488,778 25,002 $951,077
2024 0 $0 408,611 $39,133,354 286,996 $9,909,174
2023 0 $0 141,187 $7,784,005 94,629 $1,126,801
2022 6,100 $348,278 159,883 $9,751,206 120,909 $1,241,801
2021 10 $826 192,834 $19,436,304 179,740 $3,196,055
2020 0 $0 305,417 $26,920,259 283,708 $4,187,344
2019 0 $0 264,867 $22,903,303 243,844 $3,021,582
2018 0 $0 178,188 $14,439,401 140,407 $1,091,175
2017 0 $0 1,340,641 $52,437,727 116,029 $1,958,925
2016 0 $0 215,714 $5,484,336 19,167 $32,162
2015 125,000 $2,250,000 1,064,767 $22,011,197 0 $0


Table 3. Detailed insider trading at Blueprint Medicines Corp (BPMC) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2022-08-08 Albers Jeffrey W. Option Ex 10,000 5.33 53,350
2022-08-05 Murray Christopher K. (SVP, TECHNICAL OPERATIONS) Sale 2,500 65.00 162,500
2022-08-04 Murray Christopher K. (SVP, TECHNICAL OPERATIONS) Sale 2,500 60.44 151,100
2022-06-07 Hewes L. Becker (CHIEF MEDICAL OFFICER) Sale 3,155 60.00 189,300
2022-06-06 Carter Percy H. (CHIEF SCIENTIFIC OFFICER) Sale 1,908 59.76 114,022
2022-06-06 Hewes L. Becker (CHIEF MEDICAL OFFICER) Sale 1,220 59.76 72,907
2022-05-23 Lydon Nicholas Option Ex 10,909 19.53 213,052
2022-05-16 Albers Jeffrey W. Sale 20,000 55.44 1,108,800
2022-05-16 Albers Jeffrey W. Option Ex 20,000 8.44 168,800
2022-04-06 Albers Jeffrey W. (CEO AND PRESIDENT) Sale 5,000 70.11 350,550
2022-04-06 Albers Jeffrey W. (CEO AND PRESIDENT) Option Ex 5,000 15.01 75,050
2022-03-17 Demetri George Sale 10 58.56 585
2022-03-16 Hewes L. Becker (CHIEF MEDICAL OFFICER) Sale 2,219 60.00 133,140
2022-03-10 Hurley Ariel (PRINCIPAL ACCOUNTING OFFICER) Sale 2,339 57.15 133,673
2022-03-07 Hewes L. Becker (CHIEF MEDICAL OFFICER) Sale 1,047 56.19 58,830
2022-03-07 Namouni Fouad (PRESIDENT, R & D) Sale 1,047 56.19 58,830
2022-03-07 Durso-bumpus Debra (CHIEF PEOPLE OFFICER) Sale 1,047 56.19 58,830
2022-03-07 Hurley Ariel (PRINCIPAL ACCOUNTING OFFICER) Sale 256 56.19 14,384
2022-03-07 Rossi Christina (CHIEF COMMERCIAL OFFICER) Sale 1,047 56.19 58,830
2022-03-07 Murray Christopher K. (SVP, TECHNICAL OPERATIONS) Sale 502 56.19 28,207
2022-03-07 Mccain Tracey L (EVP AND CHIEF LEGAL OFFICER) Sale 1,047 56.19 58,830
2022-03-07 Haviland Kate (CHIEF OPERATING OFFICER) Sale 1,048 56.18 58,876
2022-03-07 Landsittel Michael (CHIEF FINANCIAL OFFICER) Sale 1,047 56.19 58,830
2022-03-07 Albers Jeffrey W. (CEO AND PRESIDENT) Sale 4,843 56.19 272,128
2022-03-04 Albers Jeffrey W. (CEO AND PRESIDENT) Sale 20,000 57.99 1,159,900
2022-03-04 Albers Jeffrey W. (CEO AND PRESIDENT) Option Ex 20,000 8.44 168,800
2022-03-03 Durso-bumpus Debra (CHIEF PEOPLE OFFICER) Sale 1,491 60.27 89,862
2022-03-03 Hurley Ariel (PRINCIPAL ACCOUNTING OFFICER) Sale 761 60.27 45,865
2022-03-03 Rossi Christina (CHIEF COMMERCIAL OFFICER) Sale 1,197 60.28 72,155
2022-03-03 Murray Christopher K. (SVP, TECHNICAL OPERATIONS) Sale 1,066 60.27 64,247
2022-03-03 Mccain Tracey L (EVP AND CHIEF LEGAL OFFICER) Sale 1,667 60.28 100,486
2022-03-03 Haviland Kate (CHIEF OPERATING OFFICER) Sale 1,719 60.27 103,604
2022-03-03 Landsittel Michael (CHIEF FINANCIAL OFFICER) Sale 1,328 60.27 80,038
2022-03-03 Albers Jeffrey W. (CEO AND PRESIDENT) Sale 7,862 60.28 473,921
2022-03-03 Goldberg Mark Alan Buy 5,000 59.98 299,900
2021-12-15 Hewes L. Becker (Chief Medical Officer) Sale 729 100.00 72,900
2021-12-15 Hewes L. Becker (Chief Medical Officer) Option Ex 729 66.24 48,288
2021-12-13 Haviland Kate (Chief Operating Officer) Sale 1,000 98.13 98,133
2021-12-13 Haviland Kate (Chief Operating Officer) Option Ex 1,000 36.05 36,050
2021-12-07 Mccain Tracey L (EVP and Chief Legal Officer) Sale 5,000 96.46 482,299
2021-12-07 Mccain Tracey L (EVP and Chief Legal Officer) Option Ex 5,000 28.36 141,800
2021-11-16 Hurley Ariel (Principal Accounting Officer) Sale 1,950 114.28 222,846
2021-11-16 Hurley Ariel (Principal Accounting Officer) Option Ex 1,950 8.56 16,692
2021-11-15 Hewes L. Becker (Chief Medical Officer) Sale 729 115.49 84,192
2021-11-15 Hewes L. Becker (Chief Medical Officer) Option Ex 729 66.24 48,288
2021-11-15 Albers Jeffrey W. (CEO and President) Sale 30,000 113.51 3,405,300
2021-11-15 Albers Jeffrey W. (CEO and President) Option Ex 30,000 8.44 253,199
2021-11-03 Rossi Christina (CHIEF COMMERCIAL OFFICER) Sale 511 110.85 56,644
2021-11-03 Mccain Tracey L (EVP and Chief Legal Officer) Sale 5,000 110.19 550,925
2021-11-03 Mccain Tracey L (EVP and Chief Legal Officer) Option Ex 5,000 28.36 141,800
2021-11-01 Durso-bumpus Debra (Chief People Officer) Sale 5,177 112.91 584,519
2021-11-01 Durso-bumpus Debra (Chief People Officer) Option Ex 5,177 27.02 139,908
2021-11-01 Albers Jeffrey W. (CEO and President) Sale 5,000 115.16 575,800
2021-11-01 Albers Jeffrey W. (CEO and President) Option Ex 5,000 15.01 75,050
2021-10-15 Hewes L. Becker (Chief Medical Officer) Sale 729 102.66 74,839
2021-10-15 Hewes L. Becker (Chief Medical Officer) Option Ex 729 66.24 48,288
2021-10-05 Namouni Fouad (President, R & D) Sale 3,241 98.18 318,201
2021-09-23 Durso-bumpus Debra (Chief People Officer) Sale 848 110.01 93,288
2021-09-23 Durso-bumpus Debra (Chief People Officer) Option Ex 848 36.05 30,570
2021-09-23 Hurley Ariel (Principal Accounting Officer) Sale 600 110.00 66,000
2021-09-23 Hurley Ariel (Principal Accounting Officer) Option Ex 600 15.01 9,006
2021-09-23 Mccain Tracey L (EVP and Chief Legal Officer) Sale 25,000 108.78 2,719,425
2021-09-23 Mccain Tracey L (EVP and Chief Legal Officer) Option Ex 25,000 28.36 709,000
2021-09-15 Hewes L. Becker (Chief Medical Officer) Sale 11,833 100.52 1,189,453
2021-09-15 Hewes L. Becker (Chief Medical Officer) Option Ex 8,750 66.24 579,600
2021-09-13 Hurley Ariel (Principal Accounting Officer) Sale 600 100.00 60,000
2021-09-13 Hurley Ariel (Principal Accounting Officer) Option Ex 600 15.01 9,006
2021-09-13 Haviland Kate (Chief Operating Officer) Sale 1,000 99.27 99,274
2021-09-13 Haviland Kate (Chief Operating Officer) Option Ex 1,000 36.05 36,050
2021-08-26 Albers Jeffrey W. (CEO and President) Option Ex 16,000 1.87 29,920
2021-08-19 Albers Jeffrey W. (CEO and President) Sale 25,000 92.61 2,315,250
2021-08-19 Albers Jeffrey W. (CEO and President) Option Ex 25,000 8.44 211,000
2021-08-17 Hurley Ariel (Principal Accounting Officer) Sale 1,350 91.93 124,105
2021-08-17 Hurley Ariel (Principal Accounting Officer) Option Ex 1,350 5.33 7,202
2021-07-13 Demetri George Buy 10 82.66 826
2021-06-02 Hewes L. Becker (Chief Medical Officer) Sale 1,292 89.03 115,026
2021-06-01 Hurley Ariel (Principal Accounting Officer) Sale 237 91.67 21,725
2021-05-12 Albers Jeffrey W. (CEO and President) Sale 25,000 92.61 2,315,325
2021-05-12 Albers Jeffrey W. (CEO and President) Option Ex 25,000 8.44 211,000
2021-03-15 Haviland Kate (Chief Operating Officer) Sale 1,000 106.46 106,458
2021-03-15 Haviland Kate (Chief Operating Officer) Option Ex 1,000 36.05 36,050
2021-03-04 Durso-bumpus Debra (Chief People Officer) Sale 1,693 87.78 148,620
2021-03-04 Hurley Ariel (Principal Accounting Officer) Sale 857 87.92 75,351
2021-03-04 Rossi Christina (Chief Commercial Officer) Sale 1,359 87.86 119,394
2021-03-04 Murray Christopher K. (SVP, Technical Operations) Sale 1,210 87.81 106,256
2021-03-04 Mccain Tracey L (EVP and Chief Legal Officer) Sale 1,893 87.81 166,214
2021-03-04 Haviland Kate (Chief Operating Officer) Sale 1,952 87.85 171,483
2021-03-04 Landsittel Michael (Chief Financial Officer) Sale 1,507 87.80 132,307
2021-03-04 Albers Jeffrey W. (CEO and President) Sale 18,986 89.65 1,702,075
2021-03-04 Albers Jeffrey W. (CEO and President) Option Ex 10,000 8.80 88,000
2021-03-03 Hurley Ariel (Principal Accounting Officer) Sale 515 98.45 50,701
2021-03-01 Hurley Ariel (Principal Accounting Officer) Sale 1,700 99.51 169,167
2021-03-01 Hurley Ariel (Principal Accounting Officer) Option Ex 1,700 5.33 9,069
2021-02-22 Dorsch Marion (Chief Scientific Officer) Sale 7,578 100.00 757,800
2021-02-22 Dorsch Marion (Chief Scientific Officer) Option Ex 7,578 37.11 281,219
2021-01-04 Demetri George Sale 758 112.15 85,009
2020-12-24 Goldberg Mark Alan Sale 5,455 125.00 681,875
2020-12-24 Goldberg Mark Alan Option Ex 5,455 28.15 153,558
2020-12-18 Goldberg Mark Alan Sale 5,454 120.00 654,480
2020-12-18 Goldberg Mark Alan Option Ex 5,454 28.15 153,530
2020-12-17 Rowland Charles A Jr Sale 10,909 117.82 1,285,298
2020-12-17 Rowland Charles A Jr Option Ex 10,909 19.53 213,052
2020-12-14 Dorsch Marion (Chief Scientific Officer) Sale 4,600 119.00 547,400
2020-12-14 Dorsch Marion (Chief Scientific Officer) Option Ex 4,600 37.11 170,706
2020-12-14 Albers Jeffrey W. (CEO and President) Sale 5,000 119.18 595,900
2020-12-14 Albers Jeffrey W. (CEO and President) Option Ex 5,000 8.80 44,000
2020-12-14 Boral Anthony L. (Chief Medical Officer) Sale 10,000 117.80 1,177,970
2020-12-14 Boral Anthony L. (Chief Medical Officer) Option Ex 10,000 15.01 150,100
2020-12-11 Goldberg Mark Alan Sale 5,455 115.00 627,325
2020-12-11 Goldberg Mark Alan Option Ex 5,455 28.15 153,558
2020-12-01 Hurley Ariel (Principal Accounting Officer) Sale 1,038 109.54 113,702
2020-12-01 Hurley Ariel (Principal Accounting Officer) Option Ex 900 8.80 7,920
2020-12-01 Goldberg Mark Alan Sale 5,454 110.00 599,940
2020-12-01 Goldberg Mark Alan Option Ex 5,454 28.15 153,530
2020-11-16 Hurley Ariel (Principal Accounting Officer) Sale 1,700 100.92 171,564
2020-11-16 Hurley Ariel (Principal Accounting Officer) Option Ex 1,700 5.33 9,069
2020-11-16 Haviland Kate (Chief Operating Officer) Sale 409 100.27 41,010
2020-11-16 Haviland Kate (Chief Operating Officer) Option Ex 409 36.05 14,744
2020-11-16 Albers Jeffrey W. (CEO and President) Sale 20,000 98.85 1,977,000
2020-11-16 Albers Jeffrey W. (CEO and President) Option Ex 20,000 8.80 176,000
2020-11-03 Rossi Christina (Chief Commercial Officer) Sale 345 99.69 34,393
2020-11-03 Rowland Charles A Jr Sale 5,522 98.52 544,010
2020-11-03 Rowland Charles A Jr Option Ex 5,522 9.46 52,238
2020-11-02 Rowland Charles A Jr Sale 4,478 99.11 443,814
2020-11-02 Rowland Charles A Jr Option Ex 4,478 9.46 42,361
2020-10-23 Boral Anthony L. (Chief Medical Officer) Option Ex 9,183 11.90 109,323
2020-10-19 Goldberg Mark Alan Sale 5,455 105.00 572,775
2020-10-19 Goldberg Mark Alan Option Ex 5,455 19.53 106,536
2020-10-16 Haviland Kate (Chief Operating Officer) Sale 13,334 101.55 1,354,027
2020-10-16 Haviland Kate (Chief Operating Officer) Option Ex 13,334 36.05 480,690
2020-10-07 Hurley Ariel (Principal Accounting Officer) Sale 600 100.00 60,000
2020-10-07 Hurley Ariel (Principal Accounting Officer) Option Ex 600 8.80 5,280
2020-10-07 Albers Jeffrey W. (CEO and President) Sale 5,000 99.17 495,850
2020-10-07 Albers Jeffrey W. (CEO and President) Option Ex 5,000 8.80 44,000
2020-10-07 Goldberg Mark Alan Sale 5,454 100.00 545,400
2020-10-07 Goldberg Mark Alan Option Ex 5,454 19.53 106,516
2020-10-06 Dorsch Marion (Chief Scientific Officer) Sale 4,600 99.00 455,400
2020-10-06 Dorsch Marion (Chief Scientific Officer) Option Ex 4,600 37.11 170,706
2020-10-01 Lydon Nicholas Sale 9,815 92.87 911,548
2020-09-23 Durso-bumpus Debra (Chief People Officer) Sale 1,900 90.02 171,038
2020-09-23 Durso-bumpus Debra (Chief People Officer) Option Ex 1,900 36.05 68,495
2020-09-23 Hurley Ariel (Principal Accounting Officer) Sale 1,400 90.00 126,000
2020-09-23 Hurley Ariel (Principal Accounting Officer) Option Ex 1,400 1.87 2,618
2020-09-23 Dorsch Marion (Chief Scientific Officer) Sale 4,600 89.00 409,400
2020-09-23 Dorsch Marion (Chief Scientific Officer) Option Ex 4,600 37.11 170,706
2020-09-22 Haviland Kate (Chief Operating Officer) Sale 3,143 85.49 268,695
2020-09-22 Haviland Kate (Chief Operating Officer) Option Ex 3,143 16.28 51,168
2020-09-22 Demetri George Sale 1,704 85.00 144,840
2020-09-22 Boral Anthony L. (Chief Medical Officer) Sale 6,864 82.33 565,113
2020-09-22 Boral Anthony L. (Chief Medical Officer) Option Ex 6,864 15.01 103,028
 1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of BPMC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Blueprint Medicines Corp (symbol BPMC, CIK number 1597264) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.